Payden & Rygel Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$11M Sell
35,200
-22,700
-39% -$6.67M 0.89% 59
2024
Q1
$16.5M Buy
+57,900
New +$16.9M 0.78% 44
2023
Q3
$1.42M Buy
+5,300
New +$1.32M 0.1% 92

Other funds holding AMGN

Payden & Rygel Investment Group's AMGN Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Amgen (AMGN) stake by 39% in Q2 2024, selling an estimated $6.67M and leaving 35,200 shares worth $11M. The position accounts for 0.89% of the portfolio, ranked #59.

Payden & Rygel Investment Group first reported a position in AMGN in Q3 2023 and has held it in 3 quarters since. The position peaked at $16.5M in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Payden & Rygel Investment Group held 35,200 shares of Amgen worth $11M as of Q2 2024.
  • Payden & Rygel Investment Group sold 22,700 Amgen shares in Q2 2024, an estimated $6.67M.
  • Amgen made up 0.89% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #59 holding.
  • Payden & Rygel Investment Group first reported a position in Amgen in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's Amgen position peaked at $16.5M in Q1 2024.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.